[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Vacancy for essential drugs specialist in WHO/EDM
- From: hogerzeilh@who.ch
- Date: Wed, 24 May 2000 19:19:55 -0400 (EDT)
E-drug: Vacancy for essential drugs specialist in WHO/EDM
---------------------------------------------
Dear e-druggers,
In the Policy, Access and Rational Use (PAR) team of the WHO Department of
Essential Drugs and Medicines Policy (WHO/EDM) there are two vacancies for
Global Health Leadership Fellows; one for a health economist to work in
pharmacoeconomics and health care financing, and one for an essential drugs
specialist to work on access to tuberculosis drugs. Below is the vacancy notice
for the ED specialist.
Hans Hogerzeil
Team Coordinator, EDM/PAR
Global Health Leadership Fellows
Health Technology and Pharmaceuticals:
Essential Drugs and Medicines Policy
Call for Applications for Global Health Leadership Fellows
___________________________________________________________
With financial support from the UN Foundation and the Rockefeller Foundation,
the World Health Organization has established a Global Health Leadership
Fellowship Programme designed to enable professionals to contribute to the work
of the organization, and to benefit from their interaction with WHO, for a
period of one year. The Health Technology and Pharmaceuticals Cluster (HTP)
invites applications for the award of a GHL Fellowship tenable in the
department
of Essential Drugs and Medicines Policy (EDM).
The mission of EDM is to contribute to saving lives and improving health by
developing global guidance and collaborating with countries to promote: (1)
equitable access to essential drugs, (2) quality, safety and efficacy of
medicines, (3) rational use of medicines, and (4)Ýcompliance with international
drug control requirements. This work is carried out in collaboration
with other
technical programmes in Headquarters, notably the Communicable
Diseases cluster,
and with specialist staff in each regional office.
EDM is interested in appointing one Fellow for the Policy, Access and Rational
Use (PAR) team in the following area of the team's work:
Access to essential drugs for tuberculosis: EDM assists countries,
national and
international organisations and other departments within WHO in facilitating
access to essential drugs for tuberculosis. The main priority drugs are
combination tablets for DOTS (which need to be further developed, produced,
tested, registered and marketed) and essential drugs needed for treating
multi-drug resistant tuberculosis (most of which are unavailable or very
expensive). Moreover, the supply and quality assurance of tuberculosis drugs
needs to be integrated into existing national drug policies and national
essential drugs programmes, and sustainable financing systems need to be
developed. The workplan of the incumbent will be developed and supervised in
close collaboration with the Department of the Control, Prevention and
Eradication of Communicable Diseases (CPE) of the CDS Cluster.
Skills sought: Applicants should be pharmacists or public health specialists
with working experience in a national essential drugs programme in at least one
developing country. Knowledge and experience in drug supply management or drug
quality assurance would be an advantage. Proven writing skills, communication
skills and computer skills are essential.
CONDITIONS AND CATEGORIES OF GHL FELLOWSHIPS
GHL Fellows will not be employees of WHO but will be attached to the
Organization for a limited duration. Priority will be given to Fellows and
Mid-Career Fellows in accordance with the category descriptions below:
GHL Fellowships: for Fellows with less than five years relevant
experience since
completing postgraduate training.
Annual Stipend: US$ 36,000.
Mid-Career GHL Fellowships: for Fellows with a completed doctoral degree or
equivalent and significant relevant work experience, or without a doctoral
degree but with substantial work, research or publication experience.
Annual Stipend: US$ 58,500
WHAT AN APPLICATION SHOULD INCLUDE
People wishing to apply should send the following information, typewritten, to
the address given below (no application forms are required).
1. Full name in capital letters with the family name underlined.
2. Date of birth and nationality.
3. Name, address, telephone number, cable address, telex address/number, fax
number and e-mail address where the candidate can be contacted.
4. Educational qualifications, including place of study, date and grade
obtained (transcripts and photocopies of qualifications are not
required at this
stage).
5. A description (in not more than 12 lines) of the applicant's current post
and of the post held immediately preceding the current post.
6. A description (not exceeding 20 lines ) of the applicant's current research
interests and experience as it relates to the work plan of EDM,
7. A list of the applicant's publications and other abstracts or
presentations.
8. Length of time for which the candidate seeks the GHL Fellowship and the
approximate date at which they are able to begin work.
9. Names of two referees who are able to comment on the candidate's ability to
contribute to the work plan of EDM. Please include their addresses, telephone
numbers, cable addresses, telex addresses/numbers, fax numbers and e-mail
addresses.
Applications, which should be sent to the following address, must be
received by
31ÝJuly 2000, but will be considered until the Fellowships are filled. Further
information regarding conditions applying to the grant can be obtained from Mrs
Ann Wilberforce at the address below:
Dr Hans V. Hogerzeil, Team Coordinator/PAR
Essential Drugs and Medicines Policy
World Health Organization
1211 Geneva 27, Switzerland
Fax: (41-22) 791 4167
e-mail: wilberforcea@who.int
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
|